A RELIABILITY STUDY OF SLEDAI - A DISEASE-ACTIVITY INDEX FOR SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：0
|
作者：
HAWKER, G
GABRIEL, S
BOMBARDIER, C
GOLDSMITH, C
CARON, D
GLADMAN, D
机构：
[1] WELLESLEY COLL HOSP, DEPT MED, DIV RHEUMATOL, TORONTO M4Y 1J3, ONTARIO, CANADA
[2] MAYO CLIN & MAYO FDN, DEPT MED, DIV RHEUMATOL, ROCHESTER, MN 55905 USA
[3] MCMASTER UNIV, DEPT CLIN EPIDEMIOL & BIOSTAT, HAMILTON L8S 4L8, ONTARIO, CANADA
[4] WELLESLEY COLL HOSP, CLIN EPIDEMIOL UNIT, TORONTO M4Y 1J3, ONTARIO, CANADA
来源：
JOURNAL OF RHEUMATOLOGY | 1993年 / 20卷 / 04期
关键词：
LUPUS DISEASE ACTIVITY; SLEDAI; OUTCOME MEASURES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SLEDAI, a disease activity index for systemic lupus erythematosus (SLE) has been validated against other such indices and its reliability has been shown by specialists in SLE. To assess its reliability among less experienced clinicians, we conducted a reliability study 3 rheumatology trainees and 9 patients with SLE according to a Latin square design. SLEDAI easily distinguished between patients (p = 0.0009), and physician variability was not statistically significant (p = 0.27). Inter and intraobserver agreement were 78.7 and 98.0%, respectively. SLEDAI was thus shown to be a reliable instrument among less experienced observers for the assessment of disease activity in SLE.
引用
收藏
页码：657 / 660
页数：4
相关论文
共 50 条
  • [21] ANTIBODIES TO SM IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH DISEASE-ACTIVITY
    BARADA, FA
    ANDREWS, BS
    DAVIS, JS
    ARTHRITIS AND RHEUMATISM, 1980, 23 (06): : 652 - 652
  • [22] SERUM THROMBOMODULIN - A NOVEL MARKER OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BOEHME, MWJ
    NAWROTH, PP
    KLING, E
    LIN, J
    AMIRAL, J
    RIEDESEL, J
    RAETH, U
    SCHERBAUM, WA
    ARTHRITIS AND RHEUMATISM, 1994, 37 (04): : 572 - 577
  • [23] CARDIAC ABNORMALITIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PREVALENCE AND RELATIONSHIP TO DISEASE-ACTIVITY
    ONG, ML
    VEERAPEN, K
    CHAMBERS, JB
    LIM, MN
    MANIVASAGAR, M
    WANG, F
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1992, 34 (01) : 69 - 74
  • [24] CORRELATIONS OF GLOBAL MEASURES OF DISEASE-ACTIVITY AND TREATMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    FORTIN, PR
    WRIGHT, EA
    LEW, RA
    FOSSEL, AH
    LIANG, MH
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S365 - S365
  • [25] THE CONTRIBUTION OF DISEASE-ACTIVITY TO COGNITIVE DEFICIT IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    CARBOTTE, RM
    DENBURG, S
    LONG, A
    SINGER, J
    DENBURG, J
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1987, 9 (01) : 64 - 64
  • [26] HEALTH-STATUS, DISEASE-ACTIVITY AND SEVERITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DESSEIN, PH
    KING, PA
    STANWIX, AE
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S185 - S185
  • [27] The systemic lupus activity measure-revised, the Mexican systemic lupus erythematosus disease activity index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus
    Uribe, AG
    Vilá, LM
    McGwin, G
    Sanchez, ML
    Reveille, JD
    Alarcón, GS
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (10) : 1934 - 1940
  • [28] Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage
    Brunner, HI
    Jones, OY
    Lovell, DJ
    Johnson, AM
    Alexander, P
    Klein-Gitelman, MS
    LUPUS, 2003, 12 (08) : 600 - 606
  • [29] The relationship between systemic lupus erythematosus disease activity index (SLEDAI) and cardiac affection
    Ghany, M. Abdel
    Nader, N.
    Youssef, A.
    Kishk, Y.
    EUROPEAN HEART JOURNAL, 2015, 36 : 101 - 101
  • [30] SERUM IGE CONCENTRATIONS, DISEASE-ACTIVITY, AND ATOPIC DISORDERS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ELKAYAM, O
    TAMIR, R
    PICK, AI
    WYSENBEEK, A
    ALLERGY, 1995, 50 (01) : 94 - 96
12345